AccuHealth Monitoring™

During pre-employment physical examinations and in the process of insuring individuals, there is a reliance on health questionnaires and/or limited physical examinations, which can all too often translate into a lack of specificity and accuracy. Through AccuHealth Monitoring™, those non-specific approaches are eliminated.

By utilizing a simple, inexpensive blood test, employers can now monitor factors that determine whether a person has suffered a job-related traumatic injury and whether that traumatic injury has led to any residual consequences. Our AccuHealth Monitoring™ protocols have been developed by The Cytokine Institute and are consistent with federally-mandated Institutional Review Board guidelines. And because we are only measuring specific proteins in the blood, absolute patient anonymity is maintained and appropriately protected.

Modern medicine recognizes that traumatic injuries are mediated by cells in the body’s immune system. It is this migration and action of those cells to a traumatic site that causes many of the consequential pain, inflammation, swelling, and discomfort, among other side effects of trauma. The latter processes are controlled by the release from immune system cells of small proteins called cytokines/chemokines. During a pre-employment physical examination, AccuHealth Monitoring™ Type I measures six or more basic cytokines/chemokines circulating in the bloodstream. These proteins are known to be the primary factors in the body’s response to trauma. This information provides a baseline which will remain in an employee’s personnel file throughout their employment. Should an employee subsequently report a job-related injury, the original cytokine/chemokine panel tests can be repeated. Detected increases in particular cytokine/chemokine levels verify that a traumatic injury has transpired. When an injury is confirmed by this follow-up testing, continued measurements of the cytokine/chemokine levels can determine whether the provided treatment is appropriate and efficacious. This results in the ability to terminate unsuccessful healthcare treatments, as well as medical practices that have little to no benefits. A return to baseline cytokine/chemokine levels means there are no residuals from the injury, thereby eliminating permanent disability settlements.

AccuHealth Monitoring™ Type I

The AccuHealth Monitoring cytokine Type I protocol gives an employer and its workers compensation insurance carrier the ability to determine whether and when an employee reverts to their pre-employment, baseline level. AccuHealth™ testing provides strong evidence as to when a worker can resume their original job activities. Once there is a return to the baseline cytokine level, the ability to claim any residual or permanent side effects is virtually eliminated in light of these objective measurements. In other words, you can now obtain objective medical information proving whether a traumatic injury did or did not cause any lasting or disabling consequences.

The cost of the AccuHealth Monitoring™ Type I testing is only a few hundred dollars. This provides a cost effective ability to track whether an injury occurred, whether treatment is appropriate and should be maintained, and whether there are any residual or permanent side effects from an injury—all with a very high degree of certainty.

AccuHealth Monitoring™ Type II

Providing a basic and accurate understanding of insurance applicants, the AccuHealth Monitoring™ Type II protocol affords the determination of the overall health and well-being of that individual in comparison to known standards of normalcy. Because it provides a more complete health picture than Type I monitoring, it offers an opportunity to inform applicants of possible occult disease processes which could have acute, chronic, and/or future adverse health consequences.

AccuHealth Monitoring™ Type II is a 15-part cytokine/chemokine protocol that provides objective evidence for identifying numerous risk factors for maladies, including, but not limited to, cardiovascular disease, oncologic illnesses, spinal cord injuries, central nervous system disorders, ongoing traumatic processes, joint-related disease, fibromyalgia, autoimmune ailments, pulmonary maladies ranging from asthma to emphysema, diabetes, and cerebrovascular disease. Whether a health questionnaire was completed accurately or a pre-insurance physical examination was done thoroughly, the ability to detect and monitor numerous acute and chronic maladies can uncover and delineate a far more insightful medical picture of an about-to-be insured. By uncovering this information, individuals can be counseled to seek appropriate medical intervention and institute any necessary preventive or therapeutic medical care.


back to top